Clinical trial
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in…
NCT00080756 · City of Hope Medical Center, Other · Active, not recruiting
Key facts
| NCT number | NCT00080756 |
|---|---|
| Title | Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease |
| Official title | Biomarkers, Breast Density And Risk Reduction Perspectives In BRCA Carriers |
| Lead sponsor | City of Hope Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer |
| Intervention type | Biological, Drug, Other, Procedure |
| Interventions | therapeutic estradiol, deslorelin, therapeutic testosterone, therapeutic conventional surgery, active surveillance, quality-of-life assessment, laboratory biomarker analysis |
| Enrollment | 11 |
| Start date | Mar 11, 2004 |
| Primary completion | Sep 15, 2024 |
| Completion | Oct 15, 2024 |
| First posted | Apr 8, 2004 |
| Last update posted | Aug 28, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: